Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
QLT INC
T.QLT
Healthcare
Biotechnology
"QLT Inc is a biotechnology company conducts development and commercialization of ocular products that address the unmet medical needs of patients and clinicians."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:QLT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(0)
•••
clodo1
X
View Profile
View Bullboard History
Post by
clodo1
on Sep 22, 2015 5:11pm
Qualcomm`s partner
Take time to visite a winner for 2016. https://www.intrinsyc.com/press-release/intrinsyc-will-distribute-qualcomm-snapdragon-flight-development-board-for-drones-and-robotics/ https://www.intrinsyc
...more
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Post by
TheRock07
on Jun 08, 2015 10:11am
Halted
eom ?
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Comment by
TheRock07
on Mar 02, 2015 11:30am
RE:Very good news
This advanced drug should add about $200 million to the asset value. Watch for a move soon..
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Post by
TheRock07
on Feb 26, 2015 11:34am
Very good news
During 2014, the Company continued to advance development of QLT091001, its synthetic retinoid product candidate, for the treatment of certain inherited retinal diseases toward pivotal trials
...more
(26)
•••
prested
X
View Profile
View Bullboard History
Post by
prested
on Feb 25, 2015 1:54pm
In and out
I've been in and out of QLT for years. It never seemed to be able to get there, where there is! However, this seems as good a time to get in as ever since, as has been noted here, it seems
...more
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Comment by
TheRock07
on Feb 10, 2015 4:43pm
RE:RE:$167 US in cash
Nice to see someone else post here. Their drug should be worth $50 million but the real upside will be in the deal..
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Post by
TheRock07
on Jan 12, 2015 6:37pm
$167 US in cash
The C$ is en route to $0.80 very soon. The $167 million in US cash then becomes over $200 million in cad cash. Onwards and upwards on strong fundamentals
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Comment by
TheRock07
on Jan 10, 2015 1:46pm
RE:RE:Strong insider Buying
A steady and progressive rise in the share price much as forecast. $6 cannot be too far away...
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Comment by
TheRock07
on Dec 28, 2014 11:59am
RE:Strong insider Buying
Latest 10 SEDI filings (by transaction date) for QLT within the last 6 months [?] Amended Filing As of 11:59pm ET December 27th, 2014
...more
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Post by
TheRock07
on Dec 23, 2014 7:07am
Strong insider Buying
20,000 shares bought in the past few days. Very good sign
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Post by
TheRock07
on Dec 16, 2014 7:35am
Although hires Strategic Options consultant
QLT Inc Symbol C : QLT Shares Issued 51,185,922 Close 2014-12-15 C$ 4.06 Recent Sedar
...more
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Post by
TheRock07
on Dec 05, 2014 10:44am
Successful Phase 2 results
QLT Announces Results From Proof-of-Concept Trial With Oral Synthetic cis-Retinoid (QLT091001) in Adult Subjects With Impaired Dark Adaptation and/or Impaired Low Luminance Vision T.QLT,
...more
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Post by
TheRock07
on Dec 02, 2014 10:02pm
A sign that a new arrangement is close
VANCOUVER, British Columbia, Dec. 2, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that Sukhi Jagpal, Chief Financial Officer
...more
(0)
•••
TheRock07
X
View Profile
View Bullboard History
Comment by
TheRock07
on Oct 29, 2014 8:29pm
RE:share price
That is correct. Nor is their near $100 million US in forward tax loss pools nor their two advanced drugs. easily $7.50 per share
(2)
•••
jseyffer
X
View Profile
View Bullboard History
Post by
jseyffer
on Oct 28, 2014 10:03am
share price
their buildings and products seem not to be priced in their share price
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >